PUBLISHER: The Business Research Company | PRODUCT CODE: 1925733
PUBLISHER: The Business Research Company | PRODUCT CODE: 1925733
Cannabidiol (CBD) is a chemical compound derived from the Cannabis Sativa plant, known as hemp or cannabis. It is utilized for various health conditions, including epilepsy, anxiety, dystonia, pain, Parkinson's disease, Crohn's disease, and more. Additionally, CBD is incorporated into coffee products, skincare items, and pet treats.
The primary product types of cannabidiol encompass oil, tinctures, suppositories, transdermal patches, vape oil, isolates, creams and roll-ons, capsules, tablets, and other formulations. CBD oil is formulated by extracting CBD from cannabis plants and blending it with a carrier oil like coconut or hemp seed oil. The sources of CBD include marijuana and hemp, utilized in oil and supplement production. Applications span medical, personal use, pharmaceuticals, and wellness, with distribution through channels like hospital pharmacies, retail pharmacies, online stores, and other distribution channels.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are impacting the cannabidiol market by increasing costs of imported extraction equipment, pharmaceutical-grade processing machinery, packaging materials, and testing instruments. Producers in North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher costs for export-oriented CBD formulations. These tariffs are increasing production costs and affecting pricing strategies. However, they are also encouraging domestic cultivation, localized extraction facilities, and vertically integrated CBD supply chains.
The cannabidiol market research report is one of a series of new reports from The Business Research Company that provides cannabidiol market statistics, including cannabidiol industry global market size, regional shares, competitors with a cannabidiol market share, detailed cannabidiol market segments, market trends and opportunities, and any further data you may need to thrive in the cannabidiol industry. This cannabidiol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cannabidiol market size has grown exponentially in recent years. It will grow from $15.44 billion in 2025 to $20.34 billion in 2026 at a compound annual growth rate (CAGR) of 31.7%. The growth in the historic period can be attributed to legalization of medical cannabis in key regions, growth of alternative medicine usage, rising consumer awareness of cbd benefits, expansion of hemp cultivation, availability of cbd extraction technologies.
The cannabidiol market size is expected to see exponential growth in the next few years. It will grow to $62.61 billion in 2030 at a compound annual growth rate (CAGR) of 32.5%. The growth in the forecast period can be attributed to increasing acceptance of cbd in healthcare, rising investments in cannabinoid research, expansion of regulated cbd retail channels, growing demand for plant-based therapeutics, increasing standardization of cbd formulations. Major trends in the forecast period include increasing adoption of cbd-based therapeutics, rising demand for wellness and nutraceutical products, growing use in personal care formulations, expansion of pharmaceutical-grade cbd products, enhanced focus on regulatory compliance.
The increasing prevalence of neurological disorders is expected to drive the growth of the cannabidiol market. Neurological disorders, affecting the central and peripheral nervous systems-including the brain, spinal cord, and nerves-can be managed with cannabidiol, which helps regulate calcium homeostasis and reduce neuroinflammation. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit organization, approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, projected to rise to 13.8 million by 2060. Therefore, the growing prevalence of neurological disorders is fueling demand for cannabidiol.
Major companies in the cannabidiol market are focusing on product innovations, such as epilepsy therapeutics, to improve seizure management. Epilepsy therapeutics are drugs specifically developed to prevent, control, or treat epilepsy and improve patient outcomes. For instance, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical company, launched Clasepi, a DCGI-approved cannabidiol-based prescription drug for managing seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. Clasepi contains less than 0.1% THC, ensuring it is non-psychotropic, and has shown effectiveness where traditional antiseizure medications are inadequate.
In April 2025, Xebra Brands Ltd., a Canada-based CBD products company, acquired a 100% stake in BSK Holdings Inc., a US-based CBD company, for an undisclosed amount. Through this acquisition, Xebra aimed to expand its presence in the U.S. CBD market, accelerating entry into North America's largest hemp/CBD market. BSK Holdings specializes in e-commerce sales of premium CBD products, including popular brands like Keoni and AMMA.
Major companies operating in the cannabidiol market are Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte's Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC
North America was the largest region in the cannabidiol market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the cannabidiol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cannabidiol market consists of sales of full spectrum CBD, broad spectrum CBD and CBD isolate forms of cannabidiol products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cannabidiol Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cannabidiol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cannabidiol ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cannabidiol market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.